Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation

NCT01516567 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Primary Mediastinal Large B Cell Lymphoma

Interventions

DRUG: Etoposide, Doxorubicin, Vincristine, Cyclophosphamide, Rituximab

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

Children's Oncology Group